Cargando…

Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals

Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenberg, Tsafrir, Fournier, Jay, Stiffler, Richelle, Chase, Henry W., Almeida, Jorge R., Aslam, Haris, Deckersbach, Thilo, Cooper, Crystal, Toups, Marisa, Carmody, Tom, Kurian, Benji, Peltier, Scott, Adams, Phillip, McInnis, Melvin G., Oquendo, Maria A., Fava, Maurizio, Parsey, Ramin, McGrath, Patrick J., Weissman, Myrna, Trivedi, Madhukar, Phillips, Mary L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047617/
https://www.ncbi.nlm.nih.gov/pubmed/31462766
http://dx.doi.org/10.1038/s41380-019-0490-5
_version_ 1783502159196717056
author Greenberg, Tsafrir
Fournier, Jay
Stiffler, Richelle
Chase, Henry W.
Almeida, Jorge R.
Aslam, Haris
Deckersbach, Thilo
Cooper, Crystal
Toups, Marisa
Carmody, Tom
Kurian, Benji
Peltier, Scott
Adams, Phillip
McInnis, Melvin G.
Oquendo, Maria A.
Fava, Maurizio
Parsey, Ramin
McGrath, Patrick J.
Weissman, Myrna
Trivedi, Madhukar
Phillips, Mary L.
author_facet Greenberg, Tsafrir
Fournier, Jay
Stiffler, Richelle
Chase, Henry W.
Almeida, Jorge R.
Aslam, Haris
Deckersbach, Thilo
Cooper, Crystal
Toups, Marisa
Carmody, Tom
Kurian, Benji
Peltier, Scott
Adams, Phillip
McInnis, Melvin G.
Oquendo, Maria A.
Fava, Maurizio
Parsey, Ramin
McGrath, Patrick J.
Weissman, Myrna
Trivedi, Madhukar
Phillips, Mary L.
author_sort Greenberg, Tsafrir
collection PubMed
description Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activity moderated response to sertraline, an antidepressant medication that targets these neurotransmitters. 222 unmedicated adults with MDD randomized to receive sertraline (n=110) or placebo (n=112) in the EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care) study completed demographic and clinical assessments, and pre-treatment functional magnetic resonance imaging while performing a reward task. We tested whether an index of reward system function in the ventral striatum (VS), a key reward circuitry region, moderated differential response to sertraline versus placebo, assessed with the Hamilton Rating Scale for Depression over 8 weeks. We observed a significant moderation effect of the reward index, reflecting the temporal dynamics of VS activity, on Week-8 depression levels (Fs≥9.67,ps≤0.002). Specifically, VS responses that were abnormal with respect to predictions from reinforcement learning theory were associated with lower Week-8 depression symptoms in the sertraline versus placebo arms. Thus, a more abnormal pattern of pre-treatment VS dynamic response to reward expectancy (expected outcome value) and prediction error (difference between expected and actual outcome), likely reflecting serotonergic and dopaminergic deficits, was associated with better response to sertraline than placebo. Pre-treatment measures of reward-related VS activity may serve as objective neural markers to advance efforts to personalize interventions by guiding individual-level choice of antidepressant treatment. TRIAL REGISTRATION: NCT01407094; http://clinicaltrials.gov/show/NCT01407094
format Online
Article
Text
id pubmed-7047617
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-70476172020-06-21 Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals Greenberg, Tsafrir Fournier, Jay Stiffler, Richelle Chase, Henry W. Almeida, Jorge R. Aslam, Haris Deckersbach, Thilo Cooper, Crystal Toups, Marisa Carmody, Tom Kurian, Benji Peltier, Scott Adams, Phillip McInnis, Melvin G. Oquendo, Maria A. Fava, Maurizio Parsey, Ramin McGrath, Patrick J. Weissman, Myrna Trivedi, Madhukar Phillips, Mary L. Mol Psychiatry Article Medications to treat major depressive disorder (MDD) are not equally effective across patients. Given that neural response to rewards is altered in MDD and given that reward-related circuitry is modulated by dopamine and serotonin, we examined, for the first time, whether reward-related neural activity moderated response to sertraline, an antidepressant medication that targets these neurotransmitters. 222 unmedicated adults with MDD randomized to receive sertraline (n=110) or placebo (n=112) in the EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care) study completed demographic and clinical assessments, and pre-treatment functional magnetic resonance imaging while performing a reward task. We tested whether an index of reward system function in the ventral striatum (VS), a key reward circuitry region, moderated differential response to sertraline versus placebo, assessed with the Hamilton Rating Scale for Depression over 8 weeks. We observed a significant moderation effect of the reward index, reflecting the temporal dynamics of VS activity, on Week-8 depression levels (Fs≥9.67,ps≤0.002). Specifically, VS responses that were abnormal with respect to predictions from reinforcement learning theory were associated with lower Week-8 depression symptoms in the sertraline versus placebo arms. Thus, a more abnormal pattern of pre-treatment VS dynamic response to reward expectancy (expected outcome value) and prediction error (difference between expected and actual outcome), likely reflecting serotonergic and dopaminergic deficits, was associated with better response to sertraline than placebo. Pre-treatment measures of reward-related VS activity may serve as objective neural markers to advance efforts to personalize interventions by guiding individual-level choice of antidepressant treatment. TRIAL REGISTRATION: NCT01407094; http://clinicaltrials.gov/show/NCT01407094 2019-08-28 2020-07 /pmc/articles/PMC7047617/ /pubmed/31462766 http://dx.doi.org/10.1038/s41380-019-0490-5 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
Greenberg, Tsafrir
Fournier, Jay
Stiffler, Richelle
Chase, Henry W.
Almeida, Jorge R.
Aslam, Haris
Deckersbach, Thilo
Cooper, Crystal
Toups, Marisa
Carmody, Tom
Kurian, Benji
Peltier, Scott
Adams, Phillip
McInnis, Melvin G.
Oquendo, Maria A.
Fava, Maurizio
Parsey, Ramin
McGrath, Patrick J.
Weissman, Myrna
Trivedi, Madhukar
Phillips, Mary L.
Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
title Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
title_full Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
title_fullStr Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
title_full_unstemmed Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
title_short Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
title_sort reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047617/
https://www.ncbi.nlm.nih.gov/pubmed/31462766
http://dx.doi.org/10.1038/s41380-019-0490-5
work_keys_str_mv AT greenbergtsafrir rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT fournierjay rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT stifflerrichelle rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT chasehenryw rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT almeidajorger rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT aslamharis rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT deckersbachthilo rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT coopercrystal rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT toupsmarisa rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT carmodytom rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT kurianbenji rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT peltierscott rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT adamsphillip rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT mcinnismelving rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT oquendomariaa rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT favamaurizio rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT parseyramin rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT mcgrathpatrickj rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT weissmanmyrna rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT trivedimadhukar rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals
AT phillipsmaryl rewardrelatedventralstriatalactivityanddifferentialresponsetosertralineversusplaceboindepressedindividuals